Chengdu Liston Pharmaceutical

Chengdu Liston Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacture, and commercialization of small molecule therapeutics for chronic diseases. The company's portfolio is primarily focused on cardiovascular health, metabolic disorders, and anti-infective therapeutic areas, featuring a mix of high-end generics and innovative drug candidates. Liston operates state-of-the-art manufacturing facilities in Chengdu that meet national GMP standards and has established a strong presence in the Chinese domestic market through participation in centralized volume-based procurement. Their R&D efforts are particularly noted for improving drug delivery and efficacy in combination therapies for hypertension and diabetes. The company was among the first in China to successfully pass the consistency evaluation for several key cardiovascular medications.